Clinical trial
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple…
NCT00003490 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00003490 |
|---|---|
| Title | Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma |
| Official title | Phase II to Treat Multiple Myeloma Patients With Cytoxan and Vincristine After Cycling Myeloma Cells With rHuGM-CSF |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug |
| Interventions | sargramostim, cyclophosphamide, prednisone, vincristine sulfate |
| Enrollment | 30 |
| Start date | Oct 1, 1998 |
| Completion | Aug 1, 2003 |
| First posted | May 21, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: